BioElectronics Corporation (BIEL)

Market Cap	9.88M +185.7%
Revenue (ttm)	1.61M +94.0%
Net Income	-289.82K
EPS	-0.00
Shares Out	24.71B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,350,000
Open	0.0004
Previous Close	0.0004
Day's Range	0.0003 - 0.0004
52-Week Range	0.0001 - 0.0014
Beta	2.05
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BioElectronics

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIEL

Financial Performance

In 2021, BioElectronics's revenue was $1.61 million, an increase of 94.01% compared to the previous year's $829,563. Losses were -$289,821, -75.01% less than in 2020.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error